优化皮质甲状腺癌与哈希莫托甲状腺炎的手术结果:对单边和全甲状腺切除术的回顾性比较研究
Xiaoyong Wen1,2, Shiwei Zhou1, Wu Li1
1Department of Thyroid Surgery, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, 410013, Hunan, P. R. China.
Scientific reports
|December 29, 2024
概括
对于带有哈西莫托甲状腺炎 (HT) 的乳头甲状腺癌 (PTC),全甲状腺切除术 (TT) 可能会减少疲劳,相比单侧甲状腺切除术 (UT),特别是在甲状腺过氧化酶抗体 (TPOAB) 水平较高的患者中. 然而,TT增加了过渡性甲状腺功能低下症的风险.
科学领域:
- 内分泌学 在内分泌学.
- 手术瘤学手术瘤学
- 免疫学 免疫学 免疫学
背景情况:
- 与哈西莫托甲状腺炎 (HT) 并发的乳头甲状腺癌 (PTC) 的治疗缺乏标准化的外科手术指南.
- 甲状腺过氧化酶抗体 (TPOAB) 水平可能会影响PTC-HT患者的结果.
研究的目的:
- 为了比较PTC-HT患者的单侧甲状腺切除术 (UT) 和全甲状腺切除术 (TT).
- 评估TPOAB水平对患者报告结果 (PROM) 和手术策略选择的影响.
主要方法:
- 从2018年1月到2023年8月,对246名PTC-HT患者进行了回顾性研究.
- 倾向性得分匹配 (PSM) 用于比较UT和TT组.
- 根据手术前TPOAB水平分层的患者 (L: 100-400,M: 400-1000,H: >1000) 来分析PROM (生活质量,疲劳).
主要成果:
- 较高的TPOAB水平与增加的身体疲劳相关.
- 与UT组相比,TT组显示了手术后较低的TPOAB水平和减少的身体疲劳 (p=0.039).
- TT与更高的过渡性甲状腺功能低下症率相关 (7.8%与1.1%,p=0.030).
- 在TPOAB小组之间观察到疲劳减缓的显著差异 (L与H,M与H对身体疲劳;L与H对精神疲劳).
结论:
- 整体甲状腺切除术 (TT) 可以缓解带有哈西莫托甲状腺炎 (PTC-HT) 的乳头甲状腺癌患者的疲劳症状,特别是那些手术前甲状腺过氧化酶抗体 (TPOAB) 水平较高的患者.
- 在单边甲状腺切除术 (UT) 和TT之间进行选择时,应考虑患者特定的因素,包括TPOAB水平,以及缓解症状和并发症风险之间的权衡.
相关概念视频
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...


